HCPLive

New Mechanisms in Joint Damage and Gout

$shareThis$


Theodore Fields, MD, director, Rheumatology Faculty Practice Plan at the Hospital for Special Surgery and a professor of clinical medicine at Weill Cornell Medical College explains the new mechanisms available in gout treatment and management.
 
“We keep learning more about what happens in gout and how exactly the inflammatory process goes on,” Fields says. “We know a lot more than we did.”
 
Uric acid crystals stimulate the cells that break down bone, leading to erosions of bone in patients with gout. Fields pointed to a new study presented at ACR that is using a medicine for osteoporosis and giving it to gout patients to try and prevent some damage.

Most Popular

Recommended Reading

Male chronic pancreatitis patients receiving pancreatic enzyme replacement therapy are less likely to have osteopathy, according to research published in the Journal of the Pancreas.
The pain that typically accompanies osteoarthritis may be associated with excess mortality among middle-aged women, British scientists reported.
About 6.1 percent of U.S. allopathic medical school seniors in the National Resident Matching Program (NRMP) were not placed into first-year residency positions, with a higher percentage of unmatched seniors than in 2014, according to a report published by the American Medical Association.

The field of medical technology is constantly expanding and changing requiring new equipment to be used in a variety of ways. That effort has been brought under one roof at Massachusetts General Hospital thanks in part to the efforts of one generous and appreciative patient.
$vacMongoViewPlus$ $vAR$